MaxCyte ( (MXCT) ) has shared an announcement.
MaxCyte, Inc., a non-UK issuer, has announced a change in its major holdings, with BlackRock, Inc. increasing its voting rights in the company to 7.87% as of March 21, 2025. This adjustment in BlackRock’s holdings, which was previously at 7.81%, reflects a strategic move in the financial market, potentially impacting MaxCyte’s shareholder dynamics and market perception.
More about MaxCyte
YTD Price Performance: -25.00%
Average Trading Volume: 40,604
Technical Sentiment Signal: Strong Buy
Current Market Cap: £253.6M
See more insights into MXCT stock on TipRanks’ Stock Analysis page.